Search Results - "Pavanni, R."

Refine Results
  1. 1

    Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson’s Disease by Kumar, Prakash M., Paing, Swe Swe Thet, Li, HuiHua, Pavanni, R., Yuen, Y., Zhao, Y., Tan, Eng King

    Published in Scientific reports (02-11-2015)
    “…We examined if caffeine intake has a differential effect in subjects with high and low genetic susceptibility to Parkinson’s disease (PD), a common…”
    Get full text
    Journal Article
  2. 2

    Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus by TAN, E.-K, KWOK, H.-K, TODA, T, LIU, J.-J, TAN, L. C, ZHAO, W.-T, PRAKASH, K. M, AU, W.-L, PAVANNI, R, NG, Y.-Y, SATAKE, W, ZHAO, Y

    Published in Neurology (10-08-2010)
    “…A genome-wide association study (GWAS) in the Japanese population identified 2 new Parkinson disease (PD) susceptibility loci on 1q32 (PARK16) (OMIM 613164)…”
    Get full text
    Journal Article
  3. 3

    The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients by Tan, E.K., Shen, H., Tan, L.C.S., Farrer, M., Yew, K., Chua, E., Jamora, R.D., Puvan, K., Puong, K.Y., Zhao, Y., Pavanni, R., Wong, M.C., Yih, Yuen, Skipper, L., Liu, Jian-Jun

    Published in Neuroscience letters (26-08-2005)
    “…A common heterozygous leucine-rich repeat kinase 2 (LRRK2) mutation 6055G > A transition (G2019S) accounts for about 3–7% of familial Parkinson's disease (PD)…”
    Get full text
    Journal Article
  4. 4

    The LRRK2 Gly2385Arg variant is associated with Parkinson's disease : genetic and functional evidence by TAN, E. K, ZHAO, Y, TAN, L, PAVANNI, R, WONG, M. C, KOLATKAR, P, LU, C. S, BONIFATI, V, LIU, J. J, SKIPPER, L, TAN, M. G, DI FONZO, A, SUN, L, FOOK-CHONG, S, TANG, S, CHUA, E, YUEN, Y

    Published in Human genetics (01-02-2007)
    “…Evidence of LRRK2 haplotypes associated with Parkinson's disease (PD) risk was recently found in the Chinese population from Singapore, and a common LRRK2…”
    Get full text
    Journal Article
  5. 5

    Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese by Tan, E.-K., Tan, C., Fook-Chong, S.M.C., Lum, S.Y., Chai, A., Chung, H., Shen, H., Zhao, Y., Teoh, M.L., Yih, Y., Pavanni, R., Chandran, V.R., Wong, M.C.

    Published in Journal of the neurological sciences (15-12-2003)
    “…Introduction: Few studies have examined the relationship of coffee and tea in Parkinson's disease (PD). The potential protective effect of coffee intake and…”
    Get full text
    Journal Article
  6. 6

    LRRK2 R1628P increases risk of Parkinson’s disease: replication evidence by Tan, E. K., Tan, Louis C., Lim, H. Q., Li, R., Tang, M., Yih, Yuen, Pavanni, R., Prakash, K. M., Fook-Chong, S., Zhao, Yi

    Published in Human genetics (01-10-2008)
    “…We showed that the frequency of a LRRK2 variant (c.4883G > C, R1628P) was higher in Parkinson’s disease (PD) compared to controls (8.4 vs. 3.4%, P  = 0.046, OR…”
    Get full text
    Journal Article
  7. 7

    Complementary therapies in hemifacial spasm and comparison with other movement disorders by Peeraully, T, Hameed, S, Cheong, P T, Pavanni, R, Hussein, K, Fook-Chong, S M C, Tan, E-K

    “…We determined the prevalence, range and factors influencing the use of complementary therapy among hemifacial spasm patients and compared the patterns of use…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Analysis of LRRK2 functional domains in nondominant Parkinson disease by SKIPPER, L, SHEN, H, PAVANNI, R, WONG, M. C, YUEN, Y, FARRER, M, LIU, J. J, TAN, E. K, CHUA, E, BONNARD, C, KOLATKAR, P, TAN, L. C. S, JAMORA, R. D, PUVAN, K, PUONG, K. Y, ZHAO, Y

    Published in Neurology (25-10-2005)
    “…A comprehensive sequence analysis of 29 exons that code for the functional domains of LRRK2 in 160 nondominant Parkinson disease (PD) patients was performed…”
    Get full text
    Journal Article
  10. 10
  11. 11

    MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese by Lee, C G L, Tang, K, Cheung, Y B, Wong, L P, Tan, C, Shen, H, Zhao, Y, Pavanni, R, Lee, E J D, Wong, M-C, Chong, S S, Tan, E K

    Published in Journal of medical genetics (01-05-2004)
    “…Pathogenic mutations in several genes-including α-synuclein, Parkin, UCH-L1 (ubiquitin-C terminal hydrolase-L1) and DJ-1-have previously been identified in…”
    Get full text
    Journal Article
  12. 12

    Alpha-synuclein haplotypes implicated in risk of Parkinson's disease by TAN, E. K, CHAI, A, WONG, M. C, PUVAN, K, LO, Y. L, YAP, E, TEO, Y. Y, ZHAO, Y, TAN, C, SHEN, H, CHANDRAN, V. R, TEOH, M. L, YIH, Y, PAVANNI, R

    Published in Neurology (13-01-2004)
    “…The authors examined four- and six-loci haplotype constructs (from five single nucleotide polymorphisms and three microsatellite regions) of the…”
    Get full text
    Journal Article
  13. 13

    Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort by TAN, E. K, ZHAO, Y, YIH, Y, PAVANNI, R, WONG, M. C, NG, I. S, PUONG, K. Y, LAW, H. Y, CHAN, L. L, YEW, K, TAN, C, SHEN, H, CHANDRAN, V. R, TEOH, M. L

    Published in Neurology (27-07-2004)
    “…Among 367 subjects, the authors analyzed 167 patients with essential tremor, sporadic progressive cerebellar ataxia, multiple-system atrophy, and atypical…”
    Get full text
    Journal Article
  14. 14

    Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition : clinical association by TAN, E. K, PUONG, K. Y, WONG, M. C, PUVAN, K, ZHAO, Y, CHAN, D. K. Y, YEW, K, FOOK-CHONG, S, SHEN, H, NG, P. W, WOO, J, YUEN, Y, PAVANNI, R

    Published in Human genetics (01-12-2005)
    “…We provided data to show that the transcriptional activity of wildtype -258T in the parkin promoter region was significantly higher than the -258G variant in…”
    Get full text
    Journal Article
  15. 15

    Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease by Lim, S.W., Zhao, Y., Chua, E., Law, H.Y., Yuen, Y., Pavanni, R., Wong, M.C., Ng, I.S., Yoon, C.S., Puong, K.Y., Lim, S.H., Tan, E.K.

    Published in Neuroscience letters (31-07-2006)
    “…Recent reports of SCA2 and SCA3 patients who presented with levodopa responsive parkinsonism have generated considerable interest as they have implications for…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Prescribing pattern in Parkinson's disease: are cost and efficacy overriding factors? by Tan, E K, Yeo, A P, Tan, V, Pavanni, R, Wong, M C

    “…Information on prescribing pattern of antiparkinsonian medications and factors influencing neurologists' choice of such drugs are important considerations in…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease by TAN, E. K, SHEN, H, YUEN, Y, PAVANNI, R, WONG, M. C, PUVAN, K, ZHAO, Y, TAN, J. M. M, LIM, K. L, FOOK-CHONG, S, HU, W. P, PATERSON, M. C, CHANDRAN, V. R, YEW, K, TAN, C

    Published in Neurogenetics (01-12-2005)
    “…Altered splicing of parkin under cellular stress could lead to changes in gene expression and altered protein activity. The causative role of parkin in…”
    Get full text
    Journal Article
  20. 20